B Group, Inc.
CIK 2043476 · Holdings on Jun 30, 2025 · First reported Aug 14, 2025
Top ten holdings
Q2 2025- ADMA36.45%
- INSM13.47%
- ZLAB12.08%
- AKRO10.71%
- CLLS4.29%
- TSHA3.59%
- RARE3.45%
- SGHT3.32%
- AURA3.10%
- ASMB2.96%
Share classes counted separately93.42%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- INSMWeight decreased · -3.93 pp17.40% → 13.47%Shares -107.50K (-40.95%)
- ADMAWeight decreased · -3.50 pp39.95% → 36.45%Shares 0 (0.00%)
- AKROWeight increased · +2.18 pp8.53% → 10.71%Shares -10.05K (-4.15%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 15
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | ADMAADMA BIOLOGICS INC View history and evidence | $42.20M | 36.45% | 2.32M shares | 39.95% → 36.45%-3.50 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | INSMINSMED INCCOM PAR $.01 View history and evidence | $15.60M | 13.47% | 155.00K shares | 17.40% → 13.47%-3.93 pp -107.50K (-40.95%) | Reduced | ↗▾ |
| 03 | ZLABZAI LAB LTD-ADRADR View history and evidence | $13.99M | 12.08% | 400.00K shares | 12.56% → 12.08%-0.48 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | AKROAKERO THERAPEUTICS INC View history and evidence | $12.40M | 10.71% | 232.45K shares | 8.53% → 10.71%+2.18 pp -10.05K (-4.15%) | Reduced | ↗▾ |
| 05 | CLLSCELLECTIS - ADRSPON ADS View history and evidence | $4.97M | 4.29% | 3.26M shares | 3.51% → 4.29%+0.78 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | TSHATAYSHA GENE THERAPIES INCCOM SHS View history and evidence | $4.16M | 3.59% | 1.80M shares | 1.52% → 3.59%+2.07 pp +545.00K (+43.41%) | Added | ↗▾ |
| 07 | RAREULTRAGENYX PHARMACEUTICAL IN View history and evidence | $4.00M | 3.45% | 110.00K shares | 1.49% → 3.45%+1.96 pp +62.50K (+131.58%) | Added | ↗▾ |
| 08 | SGHTSIGHT SCIENCES INC View history and evidence | $3.84M | 3.32% | 930.00K shares | 1.74% → 3.32%+1.58 pp +96.40K (+11.56%) | Added | ↗▾ |
| 09 | AURAAURA BIOSCIENCES INC View history and evidence | $3.58M | 3.10% | 572.58K shares | 2.41% → 3.10%+0.69 pp +100.00K (+21.16%) | Added | ↗▾ |
| 10 | ASMBASSEMBLY BIOSCIENCES INCCOM NEW View history and evidence | $3.43M | 2.96% | 189.35K shares | 1.66% → 2.96%+1.30 pp -10.65K (-5.33%) | Reduced | ↗▾ |
Options overlay 2
$14.15M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
LLYELI LILLY & COPUT View history and evidence | Put | 15.00K | $11.69M | +15.00K | ▾ |
RAREULTRAGENYX PHARMACEUTICAL INCALL View history and evidence | Call | 67.60K | $2.46M | +30.00K (+79.79%) | ▾ |
2 / 2 options · preview only
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| BNTX BIONTECH SE-ADR | Non-derivative | -15,000 | -$1.37M | SEC filing ↗ | SEC filing ↗ |
| ETNB 89BIO INC | Non-derivative | -95,623 | -$695.18K | SEC filing ↗ | SEC filing ↗ |
| CRVS CORVUS PHARMACEUTICALS INC | Put | -90,000 | -$286.20K | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 2043476 · Period 2025-06-30
Data loaded 2026-09-23 · First reported 2025-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 129935291
}Take these holdings further.
This page includes 17 of 17 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 17 of 17 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"2043476","quarter":"2025Q2","page_size":100}
get_institutional_manager_history
{"cik":"2043476","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.